Translocation t(14;16) in IgM multiple myeloma

British Journal of Haematology

Volumn 155, Issue 3, 2011, Pages 402-403

  Owen, Roger G ^a   O'Connor, Sheila J M ^a   Bond, Lee R ^b   de Tute, Ruth M ^a   Rawstron, Andy C ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

IGH@ rearrangement; IgM; Myeloma; Translocation

Indexed keywords

BORTEZOMIB; CD19 ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; LENALIDOMIDE; MELPHALAN; SYNDECAN 1; THALIDOMIDE;

ADULT; ANAMNESIS; ANEMIA; ANTIGEN EXPRESSION; CANCER GROWTH; CASE REPORT; CELLULAR DISTRIBUTION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 16; CYTOGENETICS; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; STEM CELL TRANSPLANTATION;

FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MULTIPLE MYELOMA;

EID: 80053945972     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08687.x     Document Type: Letter

References (7)

1. Ackroyd, S., O'Connor, S.J., Rawstron, A.C. & Owen, R.G. (2005) IgM myeloma with t(4;14)(p16;q32). Cancer Genetics and Cytogenetics, 162, 183-184.
2. Avet-Loiseau, H., Garand, R., Lode, L., Harousseau, J.L. & Bataille, R. (2003) Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood, 101, 1570-1571.
3. Feyler, S., O'Connor, S.J.M., Rawstron, A.C., Subash, C., Ross, F.M., Pratt, G., Drayson, M.T., Ashcroft, J., Cook, G. & Owen, R.G. (2007) IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14). British Journal of Haematology, 140, 547-551.
4. Morris, C., Drake, M., Apperley, J., Iacobelli, S., van Biezen, A., Bjorkstrand, B., Goldschmidt, H., Harousseau, J.L., Morgan, G., de Witte, T., Niederwieser, D. & Gahrton, G. (2010) Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica, 95, 2126-2133.
5. Munshi, N.C., Anderson, K.C., Bergsagel, P.L., Shaughnessy, J., Palumbo, A., Durie, B., Fonseca, R., Stewart, A.K., Harousseau, J.L., Dimopoulos, M., Jagannath, S., Hajek, R., Sezer, O., Kyle, R., Sonneveld, P., Cavo, M., Rajkumar, S.V., San Miguel, J., Crowley, J. & Avet-Loiseau, H. (2011). Guidelines for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood [Epub Feb 3 2011]. doi:.
6. Schuster, S.R., Rajkumar, S.V., Dispenzieri, A., Morice, W., Aspitia, A.M., Ansell, S., Kyle, R. & Mikhael, J. (2010) IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia. American Journal of Hematology, 85, 853-855.
7. Willenbacher, E., Erdel, M., Strasser, U., Gastl, G., Schmidt, S., Gunsilius, E. & Willenbacher, W. (2008) IgM myeloma: more on a rare entity. British Journal of Haematology, 143, 143-144.